US20060280774A1
(en)
*
|
1995-06-02 |
2006-12-14 |
Allergan, Inc. |
Compositions and methods for treating glaucoma
|
US5869079A
(en)
*
|
1995-06-02 |
1999-02-09 |
Oculex Pharmaceuticals, Inc. |
Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
|
AU716005B2
(en)
|
1995-06-07 |
2000-02-17 |
Cook Medical Technologies Llc |
Implantable medical device
|
US5773019A
(en)
*
|
1995-09-27 |
1998-06-30 |
The University Of Kentucky Research Foundation |
Implantable controlled release device to deliver drugs directly to an internal portion of the body
|
US6056734A
(en)
*
|
1997-02-07 |
2000-05-02 |
Sarcos Lc |
Method for automatic dosing of drugs
|
IN186245B
(pt)
|
1997-09-19 |
2001-07-14 |
Ranbaxy Lab Ltd |
|
US6342250B1
(en)
|
1997-09-25 |
2002-01-29 |
Gel-Del Technologies, Inc. |
Drug delivery devices comprising biodegradable protein for the controlled release of pharmacologically active agents and method of making the drug delivery devices
|
DE69942348D1
(de)
|
1998-04-27 |
2010-06-17 |
Surmodics Inc |
Bioaktive Wirkstoffe freisetzende Beschichtungen
|
US7662409B2
(en)
|
1998-09-25 |
2010-02-16 |
Gel-Del Technologies, Inc. |
Protein matrix materials, devices and methods of making and using thereof
|
US20050147690A1
(en)
*
|
1998-09-25 |
2005-07-07 |
Masters David B. |
Biocompatible protein particles, particle devices and methods thereof
|
US20030007991A1
(en)
*
|
1998-09-25 |
2003-01-09 |
Masters David B. |
Devices including protein matrix materials and methods of making and using thereof
|
JP2002534139A
(ja)
*
|
1999-01-05 |
2002-10-15 |
マサチューセッツ・アイ・アンド・イア・インファーマリー |
網膜と脈絡膜への経強膜徐放性薬剤標的送達
|
CA2360938C
(en)
|
1999-02-02 |
2008-01-08 |
Warren Oliver Haggard |
Controlled release composite
|
US6198966B1
(en)
|
1999-02-26 |
2001-03-06 |
Medtronic, Inc. |
Recirculating implantable drug delivery system
|
EP1173790A2
(en)
|
1999-03-01 |
2002-01-23 |
Boston Innovative Optics, Inc. |
System and method for increasing the depth of focus of the human eye
|
US20040121014A1
(en)
*
|
1999-03-22 |
2004-06-24 |
Control Delivery Systems, Inc. |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
US6217895B1
(en)
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
JP2003511204A
(ja)
|
1999-10-21 |
2003-03-25 |
アルコン,インコーポレイティド |
テノン下薬剤送出
|
US6416777B1
(en)
|
1999-10-21 |
2002-07-09 |
Alcon Universal Ltd. |
Ophthalmic drug delivery device
|
ES2315598T3
(es)
|
1999-10-21 |
2009-04-01 |
Alcon, Inc. |
Dispositivo para la administracion de farmacos.
|
US7943162B2
(en)
*
|
1999-10-21 |
2011-05-17 |
Alcon, Inc. |
Drug delivery device
|
US8162927B2
(en)
*
|
2000-03-21 |
2012-04-24 |
Gholam A. Peyman |
Method and apparatus for accommodating intraocular lens
|
US20070031473A1
(en)
*
|
2005-08-05 |
2007-02-08 |
Peyman Gholam A |
Drug delivery system and method
|
US6478776B1
(en)
|
2000-04-05 |
2002-11-12 |
Biocardia, Inc. |
Implant delivery catheter system and methods for its use
|
AU2001253479A1
(en)
*
|
2000-04-13 |
2001-10-30 |
Sts Biopolymers, Inc. |
Targeted therapeutic agent release devices and methods of making and using the same
|
US20040115268A1
(en)
*
|
2000-04-26 |
2004-06-17 |
Control Delivery Systems, Inc. |
Systemic delivery of antiviral agents
|
US6375972B1
(en)
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
US20040208910A1
(en)
*
|
2000-04-26 |
2004-10-21 |
Control Delivery Systems, Inc. |
Sustained release device and method for ocular delivery of adrenergic agents
|
US20040175410A1
(en)
*
|
2000-04-26 |
2004-09-09 |
Control Delivery Systems, Inc. |
Sustained release device and method for ocular delivery of carbonic anhydrase inhibitors
|
US6306423B1
(en)
|
2000-06-02 |
2001-10-23 |
Allergan Sales, Inc. |
Neurotoxin implant
|
US6726918B1
(en)
|
2000-07-05 |
2004-04-27 |
Oculex Pharmaceuticals, Inc. |
Methods for treating inflammation-mediated conditions of the eye
|
US20020022795A1
(en)
*
|
2000-08-14 |
2002-02-21 |
Reynolds John R. |
Bilayer electrodes
|
DK1313415T3
(da)
*
|
2000-08-30 |
2008-10-13 |
Univ Johns Hopkins |
Indretninger til intraokulær lægemiddeladministration
|
IL155479A0
(en)
*
|
2000-11-03 |
2003-11-23 |
Control Delivery Sys Inc |
Improved device and method for treating conditions of a joint
|
WO2002043785A2
(en)
|
2000-11-29 |
2002-06-06 |
Oculex Pharmaceuticals, Inc. |
Intraocular implants for preventing transplant rejection in the eye
|
CA2434156A1
(en)
*
|
2000-12-29 |
2002-07-25 |
Bausch & Lomb Incorporated |
Sustained release drug delivery devices
|
JP2004522730A
(ja)
*
|
2001-01-03 |
2004-07-29 |
ボシュ・アンド・ロム・インコーポレイテッド |
コーティングされた薬剤コアを備えた徐放薬剤送達装置
|
ES2320533T3
(es)
|
2001-01-03 |
2009-05-25 |
BAUSCH & LOMB INCORPORATED |
Dispositivos de administracion de farmacos de liberacion sostenida con multiples agentes.
|
US6964781B2
(en)
*
|
2001-01-03 |
2005-11-15 |
Bausch & Lomb Incorporated |
Sustained release drug delivery devices with prefabricated permeable plugs
|
EP1847255A3
(en)
*
|
2001-01-03 |
2009-03-04 |
Bausch & Lomb Incorporated |
Sustained release drug delivery devices with coated drug cores
|
JP2004520900A
(ja)
*
|
2001-01-26 |
2004-07-15 |
ボシュ・アンド・ロム・インコーポレイテッド |
徐放薬剤送達装置の改良製造方法
|
WO2002060486A2
(en)
*
|
2001-01-29 |
2002-08-08 |
Fresco Bernard B |
Controlled release microsphere system for administration of drug to the eye
|
US6713081B2
(en)
*
|
2001-03-15 |
2004-03-30 |
The United States Of America As Represented By The Department Of Health And Human Services |
Ocular therapeutic agent delivery devices and methods for making and using such devices
|
US7431710B2
(en)
|
2002-04-08 |
2008-10-07 |
Glaukos Corporation |
Ocular implants with anchors and methods thereof
|
US20040022853A1
(en)
*
|
2001-04-26 |
2004-02-05 |
Control Delivery Systems, Inc. |
Polymer-based, sustained release drug delivery system
|
MXPA03009727A
(es)
*
|
2001-04-26 |
2004-01-29 |
Control Delivery Sys Inc |
SISTEMA DE SUMINISTRO DE FaRMACOS DE LIBERACIoN PROLONGADA QUE CONTIENE COFARMACOS.
|
WO2002089767A1
(en)
|
2001-05-03 |
2002-11-14 |
Massachusetts Eye And Ear Infirmary |
Implantable drug delivery device and use thereof
|
JP4677538B2
(ja)
|
2001-06-12 |
2011-04-27 |
ジョンズ ホプキンズ ユニヴァーシティ スクール オヴ メディシン |
眼内薬物送達のためのリザーバデバイス
|
PL204645B1
(pl)
*
|
2001-07-23 |
2010-01-29 |
Alcon |
Okulistyczne urządzenie do podawania leków
|
MXPA03011609A
(es)
|
2001-07-23 |
2004-07-01 |
Alcon Inc |
Dispositivo de entrega de droga oftalmica.
|
ES2393101T3
(es)
*
|
2001-08-29 |
2012-12-18 |
Ricardo A. P. De Carvalho |
Sistema implantable y sellable para la administración unidireccional de agentes terapéuticos a tejidos diana
|
US7749528B2
(en)
*
|
2001-08-29 |
2010-07-06 |
Ricardo Azevedo Pontes De Carvalho |
Implantable and sealable medical device for unidirectional delivery of therapeutic agents to tissues
|
IN2014DN10834A
(pt)
*
|
2001-09-17 |
2015-09-04 |
Psivida Inc |
|
US20030158598A1
(en)
*
|
2001-09-17 |
2003-08-21 |
Control Delivery Systems, Inc. |
System for sustained-release delivery of anti-inflammatory agents from a coated medical device
|
US20060034929A1
(en)
*
|
2001-12-27 |
2006-02-16 |
Brubaker Michael J |
Sustained release drug delivery devices with prefabricated permeable plugs
|
US8133501B2
(en)
|
2002-02-08 |
2012-03-13 |
Boston Scientific Scimed, Inc. |
Implantable or insertable medical devices for controlled drug delivery
|
US8685427B2
(en)
|
2002-07-31 |
2014-04-01 |
Boston Scientific Scimed, Inc. |
Controlled drug delivery
|
KR101127502B1
(ko)
*
|
2002-03-11 |
2012-03-23 |
알콘, 인코퍼레이티드 |
이식 가능한 약물 전달 시스템
|
AU2003225212A1
(en)
*
|
2002-04-29 |
2003-11-17 |
Gel-Del Technologies, Inc. |
Biomatrix structural containment and fixation systems and methods of use thereof
|
AU2003217531A1
(en)
*
|
2002-05-02 |
2003-11-17 |
Massachusetts Eye And Ear Infirmary |
Ocular drug delivery systems and use thereof
|
US8871241B2
(en)
*
|
2002-05-07 |
2014-10-28 |
Psivida Us, Inc. |
Injectable sustained release delivery devices
|
US7097850B2
(en)
|
2002-06-18 |
2006-08-29 |
Surmodics, Inc. |
Bioactive agent release coating and controlled humidity method
|
US6976584B2
(en)
|
2002-06-26 |
2005-12-20 |
Bausch & Lomb Incorporated |
Package for surgical implant
|
US20070184089A1
(en)
*
|
2002-07-15 |
2007-08-09 |
Alcon, Inc. |
Non-Polymeric Lipophilic Pharmaceutical Implant Compositions for Intraocular Use
|
ATE382330T1
(de)
|
2002-07-15 |
2008-01-15 |
Alcon Inc |
Nichtpolymere lipophile pharmazeutische implantat-zusammensetzungen für die intraokulare anwendung
|
US8920826B2
(en)
|
2002-07-31 |
2014-12-30 |
Boston Scientific Scimed, Inc. |
Medical imaging reference devices
|
DE10238310A1
(de)
*
|
2002-08-21 |
2004-03-04 |
Erich Jaeger Gmbh |
Elektrodenanordnung
|
EP1539157B1
(en)
*
|
2002-09-18 |
2013-08-21 |
Trustees Of The University Of Pennsylvania |
Rapamycin for use in inhibiting or preventing choroidal neovascularization
|
CA2498489C
(en)
*
|
2002-09-29 |
2010-02-23 |
Surmodics, Inc. |
Method for subretinal administration of therapeutics including steroids;method for localizing pharmacodynamic action at the choroid and the retina; and related methods for treatment and/or prevention of retinal diseases
|
WO2004036182A2
(en)
*
|
2002-10-17 |
2004-04-29 |
Control Delivery Systems, Inc. |
Methods for monitoring treatment of disease
|
US7354574B2
(en)
*
|
2002-11-07 |
2008-04-08 |
Advanced Ocular Systems Limited |
Treatment of ocular disease
|
OA12977A
(en)
*
|
2002-12-19 |
2006-10-13 |
Pfizer |
2-(1H-indazol-6-ylamino)-benzamide compounds as protein kinases inhibitors useful for the treatment of ophthamic diseases.
|
CA2510296A1
(en)
*
|
2002-12-20 |
2004-07-15 |
Control Delivery Systems, Inc. |
Steroid compositions for intraocular use
|
US20050048099A1
(en)
|
2003-01-09 |
2005-03-03 |
Allergan, Inc. |
Ocular implant made by a double extrusion process
|
US20040143327A1
(en)
*
|
2003-01-17 |
2004-07-22 |
Ku David N. |
Solid implant
|
CA2513884A1
(en)
*
|
2003-01-24 |
2004-08-12 |
Control Delivery Systems, Inc. |
Controlled release of highly soluble agents
|
WO2004073551A2
(en)
*
|
2003-02-18 |
2004-09-02 |
Massachusetts Eye And Ear Infirmary |
Transscleral drug delivery device and related methods
|
AU2004212900A1
(en)
*
|
2003-02-20 |
2004-09-02 |
Alcon, Inc. |
Formulations of glucocorticoids to treat pathologic ocular angiogenesis
|
US20040171598A1
(en)
*
|
2003-02-20 |
2004-09-02 |
Bingaman David P. |
Use of steroids to treat persons suffering from ocular disorders
|
US9445901B2
(en)
*
|
2003-03-12 |
2016-09-20 |
Deger C. Tunc |
Prosthesis with sustained release analgesic
|
US20050261668A1
(en)
*
|
2003-03-28 |
2005-11-24 |
Bausch & Lomb Incorporated |
Drug delivery device
|
US7037521B2
(en)
*
|
2003-03-28 |
2006-05-02 |
Bausch & Lomb Incorporated |
Using a laser for cutting a hole in a capsule for controlled drug delivery
|
US8246974B2
(en)
|
2003-05-02 |
2012-08-21 |
Surmodics, Inc. |
Medical devices and methods for producing the same
|
US8021680B2
(en)
*
|
2003-05-02 |
2011-09-20 |
Surmodics, Inc. |
Controlled release bioactive agent delivery device
|
US7416546B2
(en)
*
|
2003-05-05 |
2008-08-26 |
Boston Scientific Scimed, Inc. |
Tissue patches and related delivery systems and methods
|
US8034048B2
(en)
*
|
2003-05-05 |
2011-10-11 |
Boston Scientific Scimed, Inc. |
Tissue patches and related delivery systems and methods
|
US7589107B2
(en)
*
|
2003-05-19 |
2009-09-15 |
Othera Holding, Inc. |
Amelioration of vitrectomy-induced cataracts
|
US20040236343A1
(en)
*
|
2003-05-23 |
2004-11-25 |
Taylor Jon B. |
Insertion tool for ocular implant and method for using same
|
RU2006101150A
(ru)
*
|
2003-06-13 |
2006-06-10 |
Алькон, Инк. (Ch) |
Композиции нестероидных противовоспалительных средств для лечения патологического ангиогенеза глаз
|
US7850660B2
(en)
*
|
2003-12-19 |
2010-12-14 |
Ethicon Endo-Surgery, Inc. |
Implantable medical device with simultaneous attachment mechanism and method
|
US7862546B2
(en)
|
2003-06-16 |
2011-01-04 |
Ethicon Endo-Surgery, Inc. |
Subcutaneous self attaching injection port with integral moveable retention members
|
US8715243B2
(en)
|
2003-06-16 |
2014-05-06 |
Ethicon Endo-Surgery, Inc. |
Injection port applier with downward force actuation
|
US8465537B2
(en)
*
|
2003-06-17 |
2013-06-18 |
Gel-Del Technologies, Inc. |
Encapsulated or coated stent systems
|
US20040265356A1
(en)
*
|
2003-06-30 |
2004-12-30 |
Bausch & Lomb Incorporated |
Drug delivery device
|
US20050054586A1
(en)
*
|
2003-06-30 |
2005-03-10 |
Bartels Stephen P. |
Treatment of ophthalmic disorders
|
KR20060082792A
(ko)
*
|
2003-07-10 |
2006-07-19 |
알콘, 인코퍼레이티드 |
안과용 약물 전달 장치
|
US7083802B2
(en)
*
|
2003-07-31 |
2006-08-01 |
Advanced Ocular Systems Limited |
Treatment of ocular disease
|
EP1660013A4
(en)
|
2003-08-26 |
2011-07-20 |
Gel Del Technologies Inc |
BIOMATERIAL AND PROTEIN BIOCOACERVATES, METHODS OF MAKING AND USING THEM
|
CA2539324A1
(en)
*
|
2003-09-18 |
2005-03-31 |
Macusight, Inc. |
Transscleral delivery
|
US7087237B2
(en)
*
|
2003-09-19 |
2006-08-08 |
Advanced Ocular Systems Limited |
Ocular solutions
|
US7083803B2
(en)
*
|
2003-09-19 |
2006-08-01 |
Advanced Ocular Systems Limited |
Ocular solutions
|
US20050181018A1
(en)
*
|
2003-09-19 |
2005-08-18 |
Peyman Gholam A. |
Ocular drug delivery
|
US20050098470A1
(en)
*
|
2003-11-12 |
2005-05-12 |
Davis Michael J. |
Kit for administration of a drug
|
WO2005051234A2
(en)
*
|
2003-11-13 |
2005-06-09 |
Control Delivery Systems, Inc. |
Injectable sustained release implant having a bioerodible matrix core and a bioerodible skin
|
US20050130906A1
(en)
*
|
2003-11-20 |
2005-06-16 |
Matier William L. |
Amelioration of macular degeneration and other ophthalmic diseases
|
US8529939B2
(en)
*
|
2003-12-08 |
2013-09-10 |
Gel-Del Technologies, Inc. |
Mucoadhesive drug delivery devices and methods of making and using thereof
|
US8162897B2
(en)
|
2003-12-19 |
2012-04-24 |
Ethicon Endo-Surgery, Inc. |
Audible and tactile feedback
|
US7211272B2
(en)
*
|
2003-12-22 |
2007-05-01 |
Bausch & Lomb Incorporated |
Drug delivery device
|
US20050137538A1
(en)
*
|
2003-12-22 |
2005-06-23 |
Bausch & Lomb Incorporated |
Drug delivery device
|
US20050136095A1
(en)
*
|
2003-12-22 |
2005-06-23 |
Brian Levy |
Drug delivery device with suture ring
|
US20050158365A1
(en)
*
|
2003-12-22 |
2005-07-21 |
David Watson |
Drug delivery device with mechanical locking mechanism
|
WO2005070333A1
(en)
|
2004-01-13 |
2005-08-04 |
Orthobiologica, Inc. |
Drug delivery to a joint
|
US20050194303A1
(en)
*
|
2004-03-02 |
2005-09-08 |
Sniegowski Jeffry J. |
MEMS flow module with filtration and pressure regulation capabilities
|
US7384550B2
(en)
|
2004-02-24 |
2008-06-10 |
Becton, Dickinson And Company |
Glaucoma implant having MEMS filter module
|
US7364564B2
(en)
|
2004-03-02 |
2008-04-29 |
Becton, Dickinson And Company |
Implant having MEMS flow module with movable, flow-controlling baffle
|
US7544176B2
(en)
|
2005-06-21 |
2009-06-09 |
Becton, Dickinson And Company |
Glaucoma implant having MEMS flow module with flexing diaphragm for pressure regulation
|
CN1964748A
(zh)
|
2004-04-06 |
2007-05-16 |
苏莫迪克斯公司 |
用于生物活性剂的涂料组合物
|
US20060018949A1
(en)
*
|
2004-04-07 |
2006-01-26 |
Bausch & Lomb Incorporated |
Injectable biodegradable drug delivery system
|
US20050232972A1
(en)
*
|
2004-04-15 |
2005-10-20 |
Steven Odrich |
Drug delivery via punctal plug
|
US20050244469A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
AU2005240078A1
(en)
*
|
2004-04-30 |
2005-11-17 |
Allergan, Inc. |
Retinoid-containing sustained release intraocular drug delivery systems and related methods of manufacturing
|
US20060024350A1
(en)
*
|
2004-06-24 |
2006-02-02 |
Varner Signe E |
Biodegradable ocular devices, methods and systems
|
CA2572223C
(en)
|
2004-06-25 |
2014-08-12 |
The Johns Hopkins University |
Angiogenesis inhibitors
|
WO2006014484A2
(en)
|
2004-07-02 |
2006-02-09 |
Surmodics, Inc. |
Methods and devices for the treatment of ocular conditions
|
JP2008504938A
(ja)
|
2004-07-02 |
2008-02-21 |
レイザー,エリオット |
治療媒体送出装置およびその送出装置を用いて治療媒体を眼に送り出す方法
|
WO2006026504A2
(en)
*
|
2004-08-27 |
2006-03-09 |
Spherics, Inc. |
Mucoadhesive oral formulations of high permeability, high solubility drugs
|
US20060045865A1
(en)
*
|
2004-08-27 |
2006-03-02 |
Spherics, Inc. |
Controlled regional oral delivery
|
US20060047250A1
(en)
*
|
2004-08-30 |
2006-03-02 |
Hickingbotham Dyson W |
Fluid delivery device
|
US7402156B2
(en)
*
|
2004-09-01 |
2008-07-22 |
Alcon, Inc. |
Counter pressure device for ophthalmic drug delivery
|
US20060046960A1
(en)
*
|
2004-09-02 |
2006-03-02 |
Mckay William F |
Controlled and directed local delivery of anti-inflammatory compositions
|
US20060046961A1
(en)
*
|
2004-09-02 |
2006-03-02 |
Mckay William F |
Controlled and directed local delivery of anti-inflammatory compositions
|
CA2581126A1
(en)
|
2004-09-24 |
2006-04-06 |
Rfe Pharma Llc |
Carboxy-amido-triazoles for the localized treatment of ocular diseases
|
US20160106717A1
(en)
|
2004-09-24 |
2016-04-21 |
Gen Pharma Holdings LLC |
Cai-based systems and methods for the localized treatment of uveitis
|
US20060068012A1
(en)
*
|
2004-09-29 |
2006-03-30 |
Bausch & Lomb Incorporated |
Process for preparing poly (vinyl alcohol) drug delivery devices with humidity control
|
US20060067978A1
(en)
*
|
2004-09-29 |
2006-03-30 |
Bausch & Lomb Incorporated |
Process for preparing poly(vinyl alcohol) drug delivery devices
|
WO2006039459A1
(en)
*
|
2004-09-30 |
2006-04-13 |
Bausch & Lomb Incorporated |
Capsule for encasing tablets for surgical insertion into the human body
|
US20060067979A1
(en)
*
|
2004-09-30 |
2006-03-30 |
Bausch & Lomb Incorporated |
Ophthalmic drug release device for multiple drug release
|
US20080275133A1
(en)
*
|
2004-09-30 |
2008-11-06 |
University Of Calfornia-San Francisco |
Local Administration of Retinoids to Treat Deficiencies in Dark Adaptation
|
US20060078592A1
(en)
*
|
2004-10-12 |
2006-04-13 |
Bausch & Lomb Incorporated |
Drug delivery systems
|
US7226435B2
(en)
*
|
2004-10-14 |
2007-06-05 |
Alcon, Inc. |
Drug delivery device
|
US20060107555A1
(en)
*
|
2004-11-09 |
2006-05-25 |
Curtis Marc D |
Universal snow plow adapter
|
US20060116682A1
(en)
*
|
2004-11-18 |
2006-06-01 |
Longo Marc N |
Surgical implant and methods of making and using the same
|
CA2588449A1
(en)
*
|
2004-11-24 |
2006-06-01 |
Therakine Corporation |
An implant for intraocular drug delivery
|
US20070276481A1
(en)
*
|
2004-12-08 |
2007-11-29 |
Renner Steven B |
Drug delivery device
|
US20060134162A1
(en)
*
|
2004-12-16 |
2006-06-22 |
Larson Christopher W |
Methods for fabricating a drug delivery device
|
US20060134175A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Stephen Bartels |
Drug eluting pharmaceutical delivery system for treatment of ocular disease and method of use
|
US20060134176A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Bausch & Lomb Incorporated |
Pharmaceutical delivery system and method of use
|
WO2006068898A1
(en)
*
|
2004-12-22 |
2006-06-29 |
Bausch & Lomb Incorporated |
Reusable drug delivery device
|
US20060134174A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Bausch & Lomb Incorporated |
Pharmaceutical delivery system and method of use
|
US20060163111A1
(en)
*
|
2004-12-23 |
2006-07-27 |
Baril Daniel J |
Device holder apparatus
|
US8663639B2
(en)
*
|
2005-02-09 |
2014-03-04 |
Santen Pharmaceutical Co., Ltd. |
Formulations for treating ocular diseases and conditions
|
PL1848431T3
(pl)
*
|
2005-02-09 |
2016-08-31 |
Santen Pharmaceutical Co Ltd |
Ciekłe formulacje do leczenia chorób lub stanów
|
WO2006110487A1
(en)
*
|
2005-04-08 |
2006-10-19 |
Surmodics, Inc. |
Sustained release implants for subretinal delivery
|
WO2006122414A1
(en)
*
|
2005-05-17 |
2006-11-23 |
Matregen Corp. |
Depot for sustained and controlled delivery of methotrexate
|
WO2006127592A2
(en)
*
|
2005-05-26 |
2006-11-30 |
Othera Pharmaceuticals, Inc. |
Use of hydroxylamine derivates for inhibiting vitrectomy-induced cataracts
|
US20070026047A1
(en)
*
|
2005-06-21 |
2007-02-01 |
Li-Chun Tsou |
Thermal effect on crystalinity for drug delivery devices
|
US7918844B2
(en)
|
2005-06-24 |
2011-04-05 |
Ethicon Endo-Surgery, Inc. |
Applier for implantable medical device
|
US7651483B2
(en)
|
2005-06-24 |
2010-01-26 |
Ethicon Endo-Surgery, Inc. |
Injection port
|
US20060292202A1
(en)
*
|
2005-06-27 |
2006-12-28 |
Bausch & Lomb Incorporated |
Drug delivery device
|
AU2006270041B2
(en)
|
2005-07-18 |
2011-08-18 |
Minu, Llc |
Enhanced ocular neuroprotection/neurostimulation
|
US20070014760A1
(en)
*
|
2005-07-18 |
2007-01-18 |
Peyman Gholam A |
Enhanced recovery following ocular surgery
|
NZ565953A
(en)
|
2005-07-27 |
2012-01-12 |
Univ Florida |
Small compounds that correct protein misfolding and uses thereof
|
US20070060887A1
(en)
*
|
2005-08-22 |
2007-03-15 |
Marsh David A |
Ophthalmic injector
|
ATE543914T1
(de)
*
|
2005-09-01 |
2012-02-15 |
Bristol Myers Squibb Co |
Biomarker und verfahren zur bestimmung der empfindlichkeit gegen vegfr2 modulator.
|
US20070134244A1
(en)
*
|
2005-10-14 |
2007-06-14 |
Alcon, Inc. |
Combination treatment for pathologic ocular angiogenesis
|
ZA200804550B
(en)
|
2005-11-09 |
2009-08-26 |
Combinatorx Inc |
Methods, compositions, and kits for the treatment of medical conditions
|
MX2008006379A
(es)
|
2005-11-29 |
2009-03-03 |
Smithkline Beecham Corp |
Metodo de tratamiento.
|
US7756524B1
(en)
|
2006-01-31 |
2010-07-13 |
Nextel Communications Inc. |
System and method for partially count-based allocation of vocoder resources
|
US20070178138A1
(en)
*
|
2006-02-01 |
2007-08-02 |
Allergan, Inc. |
Biodegradable non-opthalmic implants and related methods
|
JP5528708B2
(ja)
|
2006-02-09 |
2014-06-25 |
参天製薬株式会社 |
安定な製剤ならびにそれらを調製および使用する方法
|
US20070203190A1
(en)
*
|
2006-02-22 |
2007-08-30 |
Ghanshyam Patil |
Hydroxylamines and derivatives for the inhibition of complement activation
|
CA2645488C
(en)
*
|
2006-03-23 |
2014-09-02 |
Macusight, Inc. |
Formulations comprising rapamycin and methods using same for vascular permeability-related diseases or conditions
|
KR20110038144A
(ko)
|
2006-03-31 |
2011-04-13 |
큐엘티 플러그 딜리버리, 인코포레이티드 |
비루관계에 대한 약물 전달 방법, 구조, 및 조성물
|
US20070270750A1
(en)
*
|
2006-05-17 |
2007-11-22 |
Alcon, Inc. |
Drug delivery device
|
US7811252B2
(en)
*
|
2006-05-17 |
2010-10-12 |
Alcon Research, Ltd. |
Dosage control device
|
US7674243B2
(en)
*
|
2006-05-17 |
2010-03-09 |
Alcon Inc. |
Ophthalmic injection device using piezoelectric array
|
US7862540B2
(en)
*
|
2006-05-17 |
2011-01-04 |
Alcon Research, Ltd. |
Ophthalmic injection device using shape memory alloy
|
US7887521B2
(en)
*
|
2006-05-17 |
2011-02-15 |
Alcon Research, Ltd. |
Ophthalmic injection system
|
US20070270768A1
(en)
*
|
2006-05-17 |
2007-11-22 |
Bruno Dacquay |
Mechanical Linkage Mechanism For Ophthalmic Injection Device
|
US20070268340A1
(en)
*
|
2006-05-17 |
2007-11-22 |
Bruno Dacquay |
Ophthalmic Injection System and Method Using Piezoelectric Array
|
US7815603B2
(en)
*
|
2006-05-17 |
2010-10-19 |
Alcon Research, Ltd. |
Ophthalmic injection method
|
JP4827626B2
(ja)
*
|
2006-06-14 |
2011-11-30 |
キヤノン株式会社 |
被制御機器、遠隔制御システムおよび遠隔制御システムの制御方法、プログラム
|
US8802128B2
(en)
*
|
2006-06-23 |
2014-08-12 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US20070298073A1
(en)
*
|
2006-06-23 |
2007-12-27 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
JP5241714B2
(ja)
|
2006-07-07 |
2013-07-17 |
プロテウス デジタル ヘルス, インコーポレイテッド |
スマートな非経口送達システム
|
US20080033008A1
(en)
*
|
2006-08-07 |
2008-02-07 |
Ward Keith W |
Compositions and methods for treating, controlling, reducing, or ameliorating infections and sequelae thereof
|
CN101528208A
(zh)
*
|
2006-08-31 |
2009-09-09 |
博士伦公司 |
治疗或预防青光眼或其进展的组合物和方法
|
US9744137B2
(en)
*
|
2006-08-31 |
2017-08-29 |
Supernus Pharmaceuticals, Inc. |
Topiramate compositions and methods of enhancing its bioavailability
|
US20110105559A1
(en)
*
|
2006-09-11 |
2011-05-05 |
Rohrs Brian R |
Compositions and Methods for Treating, Controlling, Reducing, Ameliorating, or Preventing Allergy
|
US20110104159A1
(en)
*
|
2006-09-11 |
2011-05-05 |
Rohrs Brian R |
Compositions and methods for treating, controlling, reducing, ameliorating, or preventing allergy
|
PL2061444T3
(pl)
*
|
2006-09-11 |
2011-09-30 |
Bausch & Lomb |
Kompozycje i sposoby leczenia, traktowania, kontrolowania, redukowania, łagodzenia lub zapobiegania alergii
|
US20080097379A1
(en)
*
|
2006-09-26 |
2008-04-24 |
Alcon Manufacturing, Ltd. |
Ophthalmic injection method
|
US20080125712A1
(en)
*
|
2006-09-26 |
2008-05-29 |
Alcon Manufacturing, Ltd. |
Ophthalmic injection system
|
US20080097390A1
(en)
*
|
2006-09-27 |
2008-04-24 |
Alcon Manufacturing, Ltd. |
Spring actuated delivery system
|
US20080281292A1
(en)
*
|
2006-10-16 |
2008-11-13 |
Hickingbotham Dyson W |
Retractable Injection Port
|
CA2664160A1
(en)
*
|
2006-10-16 |
2008-09-12 |
Alcon Research, Ltd. |
Method of operating ophthalmic hand piece with disposable end
|
ES2355960T3
(es)
*
|
2006-10-16 |
2011-04-01 |
Alcon Research, Ltd. |
Conjunto de reutilización limitada recargable univaersal para pieza de mano oftálmica.
|
US9022970B2
(en)
*
|
2006-10-16 |
2015-05-05 |
Alcon Research, Ltd. |
Ophthalmic injection device including dosage control device
|
AU2007319141B2
(en)
|
2006-11-17 |
2013-01-10 |
Supernus Pharmaceuticals Inc. |
Sustained-release formulations of topiramate
|
US20080140024A1
(en)
*
|
2006-12-08 |
2008-06-12 |
Yoseph Yaacobi |
Drug delivery device
|
US20080145405A1
(en)
*
|
2006-12-15 |
2008-06-19 |
Kunzler Jay F |
Drug delivery devices
|
UY30883A1
(es)
|
2007-01-31 |
2008-05-31 |
Alcon Res |
Tapones punctales y metodos de liberacion de agentes terapeuticos
|
US20080265343A1
(en)
*
|
2007-04-26 |
2008-10-30 |
International Business Machines Corporation |
Field effect transistor with inverted t shaped gate electrode and methods for fabrication thereof
|
US20080299176A1
(en)
*
|
2007-05-30 |
2008-12-04 |
Yu-Chin Lai |
Drug delivery device comprising crosslinked polyurethane-siloxane-containing copolymers
|
US20090018512A1
(en)
*
|
2007-07-13 |
2009-01-15 |
Charles Steven T |
Pneumatically-Powered Ophthalmic Injector
|
US20090018548A1
(en)
*
|
2007-07-13 |
2009-01-15 |
Charles Steven T |
Pneumatically-Powered Intraocular Lens Injection Device with Removable Cartridge
|
US7740619B2
(en)
*
|
2007-08-01 |
2010-06-22 |
Alcon Research, Ltd. |
Spring driven ophthalmic injection device with safety actuator lockout feature
|
US7629768B2
(en)
*
|
2007-08-03 |
2009-12-08 |
Alcon Research, Ltd. |
Easy cleaning C-shaped charging base
|
US20090036842A1
(en)
*
|
2007-08-03 |
2009-02-05 |
Raffi Pinedjian |
Consumable Activation Lever For Injection Device
|
US8092541B2
(en)
*
|
2007-08-03 |
2012-01-10 |
Warsaw Orthopedic, Inc. |
Method of using an anti-growth matrix as a barrier for cell attachment and osteo-inductive factors
|
US20090042936A1
(en)
*
|
2007-08-10 |
2009-02-12 |
Ward Keith W |
Compositions and Methods for Treating or Controlling Anterior-Segment Inflammation
|
US7910123B2
(en)
*
|
2007-09-05 |
2011-03-22 |
Warsaw Orthopedic |
Methods of treating a trauma or disorder of the knee joint by local administration and sustained-delivery of a biological agent
|
US20090062922A1
(en)
*
|
2007-09-05 |
2009-03-05 |
Mckay William F |
Method and apparatus for delivering treatment to a joint
|
CA2698580C
(en)
*
|
2007-09-07 |
2016-10-11 |
Qlt Plug Delivery, Inc. |
Lacrimal implant detection
|
WO2009035567A2
(en)
*
|
2007-09-07 |
2009-03-19 |
Qlt Plug Delivery, Inc |
Insertion and extraction tools for lacrimal implants
|
KR101696301B1
(ko)
|
2007-09-07 |
2017-01-13 |
마티 테라퓨틱스 인코포레이티드 |
치료 약제의 서방성 약물 코어
|
AU2008296872A1
(en)
|
2007-09-07 |
2009-03-12 |
Qlt Inc. |
Lacrimal implants and related methods
|
US20090087443A1
(en)
*
|
2007-09-27 |
2009-04-02 |
Bartels Stephen P |
Pharmacological Adjunctive Treatment Associated with Glaucoma Filtration Surgery
|
JP5668476B2
(ja)
|
2007-10-08 |
2015-02-12 |
オーリニア・ファーマシューティカルズ・インコーポレイテッドAurinia Pharmaceuticals Inc. |
カルシニューリン阻害剤またはmTOR阻害剤を含む眼科用組成物
|
WO2009055733A1
(en)
|
2007-10-25 |
2009-04-30 |
Proteus Biomedical, Inc. |
Fluid transfer port information system
|
GB0722484D0
(en)
*
|
2007-11-15 |
2007-12-27 |
Ucl Business Plc |
Solid compositions
|
EP2237770A4
(en)
*
|
2007-12-26 |
2011-11-09 |
Gel Del Technologies Inc |
BIOCOMPATIBLE PROTEIN PARTICLES, PARTICLE DEVICES AND METHODS THEREOF
|
WO2009097468A2
(en)
|
2008-01-29 |
2009-08-06 |
Kliman Gilbert H |
Drug delivery devices, kits and methods therefor
|
CN102014816B
(zh)
*
|
2008-02-18 |
2015-04-15 |
马缇医疗股份有限公司 |
泪管植入物及相关方法
|
US20100152646A1
(en)
*
|
2008-02-29 |
2010-06-17 |
Reshma Girijavallabhan |
Intravitreal injection device and method
|
US8956642B2
(en)
|
2008-04-18 |
2015-02-17 |
Medtronic, Inc. |
Bupivacaine formulation in a polyorthoester carrier
|
US8940315B2
(en)
|
2008-04-18 |
2015-01-27 |
Medtronic, Inc. |
Benzodiazepine formulation in a polyorthoester carrier
|
US20090269390A1
(en)
*
|
2008-04-25 |
2009-10-29 |
Medtronic, Inc. |
Medical devices, polymers, compositions, and methods for delivering a haloacetate
|
US9132088B2
(en)
|
2008-04-30 |
2015-09-15 |
Mati Therapeutics Inc. |
Composite lacrimal insert and related methods
|
CN102123713A
(zh)
*
|
2008-05-09 |
2011-07-13 |
Qlt栓塞输送公司 |
治疗青光眼和眼高血压的活性剂的持续释放递送
|
US20090291073A1
(en)
*
|
2008-05-20 |
2009-11-26 |
Ward Keith W |
Compositions Comprising PKC-theta and Methods for Treating or Controlling Ophthalmic Disorders Using Same
|
US8642063B2
(en)
|
2008-08-22 |
2014-02-04 |
Cook Medical Technologies Llc |
Implantable medical device coatings with biodegradable elastomer and releasable taxane agent
|
US10016534B2
(en)
|
2008-11-17 |
2018-07-10 |
Gel-Del Technologies, Inc. |
Protein biomaterial and biocoacervate vessel graft systems and methods of making and using thereof
|
US20100158980A1
(en)
|
2008-12-18 |
2010-06-24 |
Casey Kopczynski |
Drug delivery devices for delivery of therapeutic agents
|
US8623395B2
(en)
|
2010-01-29 |
2014-01-07 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
WO2010088548A1
(en)
|
2009-01-29 |
2010-08-05 |
Forsight Labs, Llc |
Posterior segment drug delivery
|
CN102395401B
(zh)
|
2009-02-12 |
2015-08-19 |
因赛普特有限责任公司 |
经由水凝胶塞的药物递送
|
US9636255B2
(en)
|
2009-02-13 |
2017-05-02 |
Dose Medical Corporation |
Uveoscleral drug delivery implant and methods for implanting the same
|
CN105997339B
(zh)
*
|
2009-02-23 |
2018-09-04 |
马缇医疗股份有限公司 |
泪腺植入物
|
US20110077270A1
(en)
*
|
2009-04-21 |
2011-03-31 |
Pfeffer Bruce A |
Compositions and Methods for Treating Ocular Inflammation with Lower Risk of Increased Intraocular Pressure
|
US8632511B2
(en)
|
2009-05-06 |
2014-01-21 |
Alcon Research, Ltd. |
Multiple thermal sensors in a multiple processor environment for temperature control in a drug delivery device
|
WO2012071476A2
(en)
|
2010-11-24 |
2012-05-31 |
David Haffner |
Drug eluting ocular implant
|
US10206813B2
(en)
|
2009-05-18 |
2019-02-19 |
Dose Medical Corporation |
Implants with controlled drug delivery features and methods of using same
|
EP3785683B1
(en)
*
|
2009-05-18 |
2023-11-01 |
Dose Medical Corporation |
Drug eluting ocular implant
|
JP5695035B2
(ja)
*
|
2009-06-03 |
2015-04-01 |
フォーサイト・ビジョン5・インコーポレイテッドForsight Vision5,Inc. |
前眼部薬物供給
|
ES2537385T3
(es)
*
|
2009-06-09 |
2015-06-08 |
Aurinia Pharmaceuticals Inc. |
Sistemas de suministro tópico para uso oftálmico
|
IN2012DN00352A
(pt)
|
2009-06-16 |
2015-08-21 |
Bikam Pharmaceuticals Inc |
|
WO2011039648A1
(en)
|
2009-09-30 |
2011-04-07 |
Glaxo Wellcome Manufacturing Pte Ltd. |
Methods of administration and treatment
|
US8177747B2
(en)
|
2009-12-22 |
2012-05-15 |
Alcon Research, Ltd. |
Method and apparatus for drug delivery
|
EP2515864A4
(en)
*
|
2009-12-23 |
2013-09-11 |
Psivida Inc |
DELAYED RELEASE DELIVERY DEVICES
|
US10166142B2
(en)
|
2010-01-29 |
2019-01-01 |
Forsight Vision4, Inc. |
Small molecule delivery with implantable therapeutic device
|
CN102946798A
(zh)
|
2010-02-01 |
2013-02-27 |
普罗秋斯数字健康公司 |
数据采集系统
|
US20110189174A1
(en)
|
2010-02-01 |
2011-08-04 |
Afshin Shafiee |
Compositions and methods for treating, reducing, ameliorating, alleviating, or inhibiting progression of, pathogenic ocular neovascularization
|
CN102905612A
(zh)
|
2010-02-01 |
2013-01-30 |
普罗秋斯数字健康公司 |
双腕式数据采集系统
|
CN105963694B
(zh)
|
2010-04-30 |
2019-11-05 |
阿雷克森制药公司 |
抗-c5a抗体和使用所述抗体的方法
|
AU2011256259A1
(en)
|
2010-05-17 |
2012-11-08 |
Novaer Holdings, Inc. |
Drug delivery devices for delivery of ocular therapeutic agents
|
AU2011285501B2
(en)
|
2010-08-05 |
2014-02-27 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
AU2011285548B2
(en)
|
2010-08-05 |
2014-02-06 |
Forsight Vision4, Inc. |
Combined drug delivery methods and apparatus
|
SI2600930T1
(sl)
|
2010-08-05 |
2021-08-31 |
Forsight Vision4, Inc. |
Injekcijska naprava za dajanje zdravila
|
US20140031769A1
(en)
|
2010-11-19 |
2014-01-30 |
Forsight Vision4, Inc. |
Therapeutic agent formulations for implanted devices
|
US9415193B2
(en)
|
2011-03-04 |
2016-08-16 |
W. L. Gore & Associates, Inc. |
Eluting medical devices
|
US10245178B1
(en)
|
2011-06-07 |
2019-04-02 |
Glaukos Corporation |
Anterior chamber drug-eluting ocular implant
|
US20120316199A1
(en)
|
2011-06-07 |
2012-12-13 |
Ward Keith W |
Compositions and methods for treating, controlling, reducing, or ameliorating inflammatory pain
|
EA032666B1
(ru)
|
2011-06-14 |
2019-06-28 |
Бикам Фармасьютикалз, Инк. |
Опсинсвязывающие лиганды и способы их применения
|
EP2726016B1
(en)
|
2011-06-28 |
2023-07-19 |
ForSight Vision4, Inc. |
An apparatus for collecting a sample of fluid from a reservoir chamber of a therapeutic device for the eye
|
US9974685B2
(en)
|
2011-08-29 |
2018-05-22 |
Mati Therapeutics |
Drug delivery system and methods of treating open angle glaucoma and ocular hypertension
|
CA2846384C
(en)
|
2011-08-29 |
2020-12-15 |
Qlt Inc. |
Sustained release delivery of active agents to treat glaucoma and ocular hypertension
|
WO2013040238A2
(en)
*
|
2011-09-13 |
2013-03-21 |
Vista Scientific Llc |
Sustained release ocular drug delivery devices and methods of manufacture
|
KR102192603B1
(ko)
*
|
2011-09-14 |
2020-12-17 |
포사이트 비젼5, 인크. |
안내 삽입물 장치 및 방법
|
US10226417B2
(en)
|
2011-09-16 |
2019-03-12 |
Peter Jarrett |
Drug delivery systems and applications
|
WO2013040247A2
(en)
|
2011-09-16 |
2013-03-21 |
Forsight Vision4, Inc. |
Fluid exchange apparatus and methods
|
WO2013058809A1
(en)
|
2011-10-19 |
2013-04-25 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
AU2012346214B2
(en)
|
2011-11-30 |
2017-09-14 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
EP2785178B1
(en)
|
2011-12-01 |
2019-05-01 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
US9545303B2
(en)
|
2011-12-02 |
2017-01-17 |
Acufocus, Inc. |
Ocular mask having selective spectral transmission
|
US9205150B2
(en)
|
2011-12-05 |
2015-12-08 |
Incept, Llc |
Medical organogel processes and compositions
|
WO2013116061A1
(en)
|
2012-02-03 |
2013-08-08 |
Forsight Vision4, Inc. |
Insertion and removal methods and apparatus for therapeutic devices
|
US9827401B2
(en)
|
2012-06-01 |
2017-11-28 |
Surmodics, Inc. |
Apparatus and methods for coating medical devices
|
US9308355B2
(en)
|
2012-06-01 |
2016-04-12 |
Surmodies, Inc. |
Apparatus and methods for coating medical devices
|
US9901715B2
(en)
|
2012-09-05 |
2018-02-27 |
W. L. Gore Associates, Inc. |
Retractable sheath devices, systems, and methods
|
US20140100530A1
(en)
|
2012-10-05 |
2014-04-10 |
Miguel A. Linares |
Attachable uterine device with integrated and time release medicinal administering component and insertion tool for implanting such a device
|
AU2013334169B2
(en)
|
2012-10-26 |
2018-03-29 |
Forsight Vision5, Inc. |
Ophthalmic system for sustained release of drug to eye
|
WO2014164703A1
(en)
|
2013-03-11 |
2014-10-09 |
University Of Florida Research Foundation, Inc. |
Delivery of card protein as therapy for occular inflammation
|
US9204962B2
(en)
|
2013-03-13 |
2015-12-08 |
Acufocus, Inc. |
In situ adjustable optical mask
|
EP2968113B8
(en)
|
2013-03-14 |
2020-10-28 |
Forsight Vision4, Inc. |
Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
|
US9427922B2
(en)
|
2013-03-14 |
2016-08-30 |
Acufocus, Inc. |
Process for manufacturing an intraocular lens with an embedded mask
|
US10517759B2
(en)
|
2013-03-15 |
2019-12-31 |
Glaukos Corporation |
Glaucoma stent and methods thereof for glaucoma treatment
|
AU2014241163B2
(en)
|
2013-03-28 |
2018-09-27 |
Forsight Vision4, Inc. |
Ophthalmic implant for delivering therapeutic substances
|
JP6340673B2
(ja)
|
2013-05-02 |
2018-06-13 |
レティナ ファウンデーション オブ ザ サウスウエストRetina Foundation Of The Southwest |
二層型眼用インプラント
|
ES2740352T3
(es)
*
|
2013-11-14 |
2020-02-05 |
Eyed Pharma |
Dispositivo ocular
|
NZ631007A
(en)
|
2014-03-07 |
2015-10-30 |
Alexion Pharma Inc |
Anti-c5 antibodies having improved pharmacokinetics
|
AU2015266850B2
(en)
|
2014-05-29 |
2019-12-05 |
Glaukos Corporation |
Implants with controlled drug delivery features and methods of using same
|
AU2015289625B2
(en)
|
2014-07-15 |
2019-10-10 |
Forsight Vision4, Inc. |
Ocular implant delivery device and method
|
US9764122B2
(en)
|
2014-07-25 |
2017-09-19 |
Warsaw Orthopedic, Inc. |
Drug delivery device and methods having an occluding member
|
US9775978B2
(en)
|
2014-07-25 |
2017-10-03 |
Warsaw Orthopedic, Inc. |
Drug delivery device and methods having a retaining member
|
SG11201700943TA
(en)
|
2014-08-08 |
2017-03-30 |
Forsight Vision4 Inc |
Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
|
US9814673B2
(en)
*
|
2014-08-12 |
2017-11-14 |
Imprimis Pharmaceuticals, Inc. |
Intraocular lens comprising pharmaceutical compositions and methods for fabricating thereof
|
US10507101B2
(en)
|
2014-10-13 |
2019-12-17 |
W. L. Gore & Associates, Inc. |
Valved conduit
|
EP3217924A4
(en)
|
2014-11-10 |
2018-07-11 |
Forsight Vision4, Inc. |
Expandable drug delivery devices and method of use
|
US20160296532A1
(en)
|
2015-04-13 |
2016-10-13 |
Forsight Vision5, Inc. |
Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
|
US10206978B2
(en)
|
2015-06-08 |
2019-02-19 |
Retinal Solutions Llc |
Norrin regulation of junction proteins and the use thereof to treat epithelial or endothelial membrane leakage induced edema
|
US10669321B2
(en)
|
2015-06-08 |
2020-06-02 |
Retinal Solutions Llc |
Retinal capillary regeneration with synthetic norrin protein
|
US10202429B2
(en)
|
2015-06-08 |
2019-02-12 |
Retinal Solutions Llc |
Norrin regulation of cellular production of junction proteins and use to treat retinal vasculature edema
|
US11925578B2
(en)
|
2015-09-02 |
2024-03-12 |
Glaukos Corporation |
Drug delivery implants with bi-directional delivery capacity
|
US10182939B2
(en)
|
2015-09-16 |
2019-01-22 |
Novartis Ag |
Hydraulic injector and methods for intra-ocular lens insertion
|
WO2017053885A1
(en)
|
2015-09-25 |
2017-03-30 |
Glaukos Corporation |
Punctal implants with controlled drug delivery features and methods of using same
|
JP6912475B2
(ja)
|
2015-11-20 |
2021-08-04 |
フォーサイト・ビジョン フォー・インコーポレーテッドForsight Vision4, Inc. |
持続放出性薬物送達機器用の多孔質構造体
|
US10076650B2
(en)
|
2015-11-23 |
2018-09-18 |
Warsaw Orthopedic, Inc. |
Enhanced stylet for drug depot injector
|
JP7009384B2
(ja)
|
2016-04-05 |
2022-01-25 |
フォーサイト・ビジョン フォー・インコーポレーテッド |
移植可能な眼薬送達デバイス
|
JP7003110B2
(ja)
|
2016-04-20 |
2022-01-20 |
ドーズ メディカル コーポレーション |
生体吸収性眼球薬物送達デバイス
|
US10549081B2
(en)
|
2016-06-23 |
2020-02-04 |
Warsaw Orthopedic, Inc. |
Drug delivery device and methods having a retaining member
|
US10434261B2
(en)
|
2016-11-08 |
2019-10-08 |
Warsaw Orthopedic, Inc. |
Drug pellet delivery system and method
|
US11406533B2
(en)
|
2017-03-17 |
2022-08-09 |
W. L. Gore & Associates, Inc. |
Integrated aqueous shunt for glaucoma treatment
|
US20190224275A1
(en)
|
2017-05-12 |
2019-07-25 |
Aurinia Pharmaceuticals Inc. |
Protocol for treatment of lupus nephritis
|
BR112020000766A2
(pt)
|
2017-07-14 |
2020-07-21 |
Cytomx Therapeutics, Inc. |
anticorpos anti-cd166 e seus usos
|
WO2019023617A1
(en)
*
|
2017-07-27 |
2019-01-31 |
University Of Utah Research Foundation |
DEVICE FOR DELIVERY OF THERAPEUTIC PRODUCT
|
EP3658184B1
(en)
|
2017-07-27 |
2023-09-06 |
Alexion Pharmaceuticals, Inc. |
High concentration anti-c5 antibody formulations
|
KR20200093581A
(ko)
|
2017-11-21 |
2020-08-05 |
포사이트 비젼4, 인크. |
확장 가능한 포트 전달 시스템을 위한 유체 교환 기기 및 사용 방법
|
CA3087410A1
(en)
|
2018-05-24 |
2019-11-28 |
Celanese EVA Performance Polymers Corporation |
Implantable device for sustained release of a macromolecular drug compound
|
US11690807B2
(en)
|
2018-05-24 |
2023-07-04 |
Celanese Eva Performance Polymers Llc |
Implantable device for sustained release of a macromolecular drug compound
|
US11628466B2
(en)
|
2018-11-29 |
2023-04-18 |
Surmodics, Inc. |
Apparatus and methods for coating medical devices
|
US11678983B2
(en)
|
2018-12-12 |
2023-06-20 |
W. L. Gore & Associates, Inc. |
Implantable component with socket
|
JP7386382B2
(ja)
|
2018-12-12 |
2023-11-27 |
カイト ファーマ インコーポレイテッド |
キメラ抗原受容体及びt細胞受容体並びに使用方法
|
US11819590B2
(en)
|
2019-05-13 |
2023-11-21 |
Surmodics, Inc. |
Apparatus and methods for coating medical devices
|
BR112022021450A2
(pt)
|
2020-04-24 |
2022-12-27 |
Millennium Pharm Inc |
O cd19 ou fragmento de ligação, método de tratamento de um câncer, composição farmacêutica, ácido nucleico, vetor, e, célula isolada
|
CN112569457B
(zh)
*
|
2020-12-10 |
2024-02-13 |
北京大学第三医院(北京大学第三临床医学院) |
一种持续给药囊管系统
|
CN117425673A
(zh)
|
2021-04-09 |
2024-01-19 |
武田药品工业株式会社 |
靶向补体因子d的抗体和其用途
|
BR112023020371A2
(pt)
|
2021-04-26 |
2024-02-06 |
Millennium Pharm Inc |
Anticorpo anti-adgre2 humanizado ou fragmento de ligação ao antígeno do mesmo, método de tratamento de um câncer, composição farmacêutica, sequência de ácido nucleico, vetor, célula isolada, e, método de tratamento de câncer
|
AU2022266584A1
(en)
|
2021-04-26 |
2023-10-12 |
Millennium Pharmaceuticals, Inc. |
Anti-clec12a antibodies and uses thereof
|
WO2023031277A1
(en)
|
2021-08-31 |
2023-03-09 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for the treatment of ocular rosacea
|
WO2023068382A2
(en)
|
2021-10-20 |
2023-04-27 |
Takeda Pharmaceutical Company Limited |
Compositions targeting bcma and methods of use thereof
|
USD1033637S1
(en)
|
2022-01-24 |
2024-07-02 |
Forsight Vision4, Inc. |
Fluid exchange device
|